Healthcare/Biotech
Bharat Biotech credited ICMR, NIV as Covaxin co-inventors after missing them initially: Government
Responding to Trinamool Congress member Sougata Roy, who had asked whether the government took any punitive action against the company for not mentioning the names of ICMR and NIV in the patent application, the Union Health and Family Welfare Minister gave a detailed reply. There was a joint Memorandum of Understanding (MoU) between ICMR, NIV and Bharat Biotech for the development of Covaxin, he said.
- Sanofi gets drug regulator nod to market RSV therapy in India
- Unaprime buys Tata Healthcare's 43.5% in Lokmanya Hospitals
- Zydus gets Mexican regulatory approval to market cancer treatment product
- Heavy metal in most chocolates may not pose health risk, researchers say
- TA Associates, 2 others offer to buy into Eye Foundation
- Govt plans crackdown on lookalike drug brands
- EU-approved medical devices' imports may be eased
- Drug MNCs for keeping patient aid plan out of trade margin formula
- Blood tests for Alzheimer's may be coming to your doctor's office. Here's what to know
- Narrative claiming vapes, e-cigarettes healthier alternatives are misleading: Experts
- Cipla expects to commence supplies to US from China plant later this year
- Mankind Pharma taps Barclays and Deutsche Bank for Rs 13,630 cr acquisition of Bharat Serums & Vaccines
- Narrative claiming vapes, e-cigarettes healthier alternatives are misleading: Experts
- Cipla expects to commence supplies to US from China plant later this year
- Mankind Pharma taps Barclays and Deutsche Bank for Rs 13,630 cr acquisition of Bharat Serums & Vaccines
- Textiles and pharma PLI schemes likely to see longer product list
- Mankind to use debt, internal accruals to fund BSV buyout
- Cipla's North America business revenue hits record high in Q1 at $250 million
Biotech
- Maharashtra government to bring new law to crack down on bogus pathology labs
- Biocon gets 4 observations from USFDA for Andhra Pradesh facility
- Ajooni Biotech ties up with Avalon Bioenergy for sustainable moringa processing
- Emcure and its subsidiary Gennova settle legal dispute with HDT Bio over mRNA technology
- Cipla gets USFDA nod to market Lanreotide injection
Healthcare
- Unaprime buys Tata Healthcare's 43.5% in Lokmanya Hospitals
- Heavy metal in most chocolates may not pose health risk, researchers say
- TA Associates, 2 others offer to buy into Eye Foundation
- EU-approved medical devices' imports may be eased
- Blood tests for Alzheimer's may be coming to your doctor's office. Here's what to know
Pharmaceuticals
Bharat Biotech credited ICMR, NIV as Covaxin co-inventors after missing them initially: Government
Zydus gets Mexican regulatory approval to market cancer treatment product
Drug MNCs for keeping patient aid plan out of trade margin formula
Cipla expects to commence supplies to US from China plant later this year
Textiles and pharma PLI schemes likely to see longer product list